Interferon-β Is More Potent Than Interferon-α in Inhibition of Human Hepatocellular Carcinoma Cell Growth When Used Alone and in Combination With Anticancer Drugs

被引：0
|
作者：
Bazarragchaa Damdinsuren
Hiroaki Nagano
Masato Sakon
Motoi Kondo
Tameyoshi Yamamoto
Koji Umeshita
Keizo Dono
Shoji Nakamori
Morito Monden
机构：
[1] Graduate School of Medicine,Department of Surgery and Clinical Oncology (E2)
[2] Osaka University,Department of Surgery and Clinical Oncology (E2)
[3] Graduate School of Medicine,undefined
[4] Osaka University,undefined
来源：
Annals of Surgical Oncology | 2003年 / 10卷
关键词：
Interferon; Anticancer drug; Cell proliferation; HCC; Combination therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background:The prognosis of advanced hepatocellular carcinoma (HCC) is extremely poor, but promising effects of chemotherapies combined with interferon (IFN) have been reported.
引用
收藏
页码：1184 / 1190
页数：6
相关论文
共 50 条
  • [1] Interferon-β is more potent than interferon-α in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs
    Damdinsuren, B
    Nagano, H
    Sakon, M
    Kondo, M
    Yamamoto, T
    Umeshita, K
    Dono, K
    Nakamori, S
    Monden, M
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (10) : 1184 - 1190
  • [2] Different effects of interferon-α and -β in combination with anticancer drugs on human hepatocellular carcinoma cell lines
    Damdinsuren, B
    Nagano, H
    Sakon, M
    Kondo, M
    Yamamoto, T
    Ota, H
    Nakamura, M
    Umeshita, K
    Dono, K
    Nakamori, S
    Monden, M
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S71 - S71
  • [3] Fluoxetine regulates cell growth inhibition of interferon-α
    Lin, Yu-Min
    Yu, Bu-Chin
    Chiu, Wen-Tai
    Sun, Hung-Yu
    Chien, Yu-Chieh
    Su, Hui-Chen
    Yen, Shu-Yang
    Lai, Hsin-Wen
    Bai, Chyi-Huey
    Young, Kung-Chia
    Tsao, Chiung-Wen
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1746 - 1754
  • [4] A comparison of the antitumor effects of interferon-α and β on human hepatocellular carcinoma cell lines
    Murata, M
    Nabeshima, S
    Kikuchi, K
    Yamaji, K
    Furusyo, N
    Hayashi, J
    [J]. CYTOKINE, 2006, 33 (03) : 121 - 128
  • [5] Inhibition of chlamydia trachomatis growth by human interferon-α:: mechanisms and synergistic effect with interferon-γ and tumor necrosis factor-α
    Ishihara, Tatsuya
    Aga, Miho
    Hino, Keiko
    Ushio, Chie
    Taniguchi, Mutsuko
    Iwaki, Kanso
    Ikeda, Masao
    Kurimoto, Masashi
    [J]. BIOMEDICAL RESEARCH-TOKYO, 2005, 26 (04): : 179 - 185
  • [6] Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-α combination chemotherapy
    Moriyama, M
    Hoshida, Y
    Kato, N
    Otsuka, M
    Yoshida, H
    Kawabe, T
    Omata, M
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (05) : 1279 - 1287
  • [7] Monotherapy with interferon-α, or combination therapy with interferon-α, interleukin-2 and 5-fluorouracil for metastatic renal cell carcinoma
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 285 - 285
  • [8] Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane
    van Koetsveld, Peter M. t
    Vitale, Giovanni
    Feelders, Richard A.
    Waaijers, Marlijn
    Sprij-Mooij, Diana M.
    de Krijger, Ronald R.
    Speel, Ernst-Jan M.
    Hofland, Johannes
    Lamberts, Steven W. J.
    de Herder, Wouter W.
    Hofland, Leo J.
    [J]. ENDOCRINE-RELATED CANCER, 2013, 20 (03) : 443 - 454
  • [9] Interferon alpha receptors are important for antiproliferative effect of interferon-α against human hepatocellular carcinoma cells
    Damdinsuren, Bazarragchaa
    Nagano, Hiroaki
    Wada, Hiroshi
    Noda, Takehiro
    Natsag, Javzandulam
    Marubashi, Shigeru
    Miyamoto, Atsushi
    Takeda, Yutaka
    Umeshita, Koji
    Doki, Yuichiro
    Dono, Keizo
    Monden, Morito
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (01) : 77 - 83
  • [10] Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma
    Tatsugami, Katsunori
    Eto, Masatoshi
    Harano, Masahiko
    Hamaguchi, Masumitsu
    Miyamoto, Toshihiro
    Morisaki, Takashi
    Furue, Masutaka
    Akashi, Koichi
    Naito, Seiji
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (08) : 694 - 698
12345